An interventional study of Heidelberg Emotion Regulation Training in Emotion Regulation, Anxiety Disorders and Depression, sponsored by Heidelberg University. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-27.
Sponsored by Heidelberg University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Emotional Regulation with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Emotional Regulation · Germany.
Among the 17 studies in Emotional Regulation with a site in Germany, this one is the 3rd largest by planned enrollment of the 16 interventional ones that give a count, is the only one that started in 2023, is one of 15 with no phase, and was the 13th registered.
548 studies on the registry are indexed under Emotional Regulation; 190 are open to participants now.
Browse Emotional Regulation studies →4 of the 17 studies in Emotional Regulation with a site in Germany are open now. Recruiting first, the newest first:
Stephanie Mehl · Sites in Germany
Ages 16–35
Heidelberg University · Sites in Germany
Ages 18–65 · Healthy volunteers
Jena University Hospital · Sites in Germany
Healthy volunteers
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 135 Emotional Regulation studies recruiting now, 36 (27%) set no upper age limit and 95 (70%) stop at 75 or younger; 47 take children under 18; 65 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 250 is above the median of 80 across 500 interventional studies indexed under Emotional Regulation.
Median enrollment 107 across the 16 interventional studies, 100 across the 1 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
Heidelberg University is the lead sponsor of 287 studies on the registry; 18 are open to participants now.
Heidelberg University has 4 studies filed under Emotional Regulation — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Emotional Regulation with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This two-armed randomized controlled trial investigates the efficacy of a web-based emotion regulation intervention in a transdiagnostic sample. The sample includes participants diagnosed with anxiety disorders, depression, eating disorders, borderline personality disorder, and healthy controls without a current psychiatric diagnosis. Participants will be randomly assigned to either the intervention group, receiving a web-based emotion regulation program, or a waitlist control group, which will have delayed intervention access after eight weeks.
The intervention is grounded in cognitive-behavioral therapy (CBT), featuring everyday emotion regulation exercises, and psychoeducation delivered through video and audio files. Outcome measures include emotion regulation abilities, well-being, anxiety, depression, eating disorder symptoms, personality pathology, and self-esteem, evaluated at four and eight weeks post-baseline.
Background:
Emotion regulation is pivotal in the pathogenesis and persistence of diverse psychopathologies. While anxiety disorders are often marked by an impaired ability to modulate acute fear responses, depressive disorders feature enduring negative affect and frequent rumination. In eating disorders, emotional dysregulation typically leads to maladaptive coping via disordered eating behaviors, whereas in borderline personality disorder, it manifests as emotional instability. The pervasiveness of emotion regulation difficulties across these diverse clinical presentations highlights a need for treatments targeting this shared mechanism. Our study aims to address this gap by testing the effectiveness of a novel web-based emotion regulation intervention in a transdiagnostic sample.
Method:
This two-armed randomized controlled trial involves participants aged 18 and above diagnosed with anxiety disorders, depression, eating disorders, borderline personality disorder, and healthy controls without psychiatric diagnoses. Participants will be randomly assigned to one of two groups:
The intervention, accessible via mobile phones or desktop browsers, employs cognitive-behavioral therapy (CBT) techniques, offering everyday emotion regulation exercises and psychoeducation through video material and audio files.
Outcome measures, including emotion regulation abilities, well-being, anxiety, depression, eating disorder symptoms, personality pathology, and self-esteem, will be assessed at four and eight weeks post-baseline.
Hypotheses:
The intervention is expected to result in improved emotion regulation abilities and well-being, along with reduced anxiety, depression, eating disorder symptoms, personality pathology, and self-esteem compared to the waitlist control group. The transdiagnostic intervention is anticipated to demonstrate superiority in addressing the diverse emotional challenges across different psychological disorders.
Additional Laboratory Study:
A subgroup of participants will be invited for a follow-up laboratory assessment of physiological indicators of emotion regulation abilities four weeks after their initial baseline measurement. We hypothesize that the intervention will lead to notable improvements in implicit emotion regulation capacity measured during a resting period and the presentation of negative emotional images. Furthermore, we anticipate observable improvements in explicit emotion regulatory skills, specifically in the downregulation of negative emotions and the upregulation of positive emotions, as assessed through a picture-viewing paradigm.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Web-based emotion regulation intervention
Behavioral: Heidelberg Emotion Regulation Training
Eight-week waiting period
The four-week intervention program is specifically designed to enhance the participants' emotion regulation. It focuses on developing their skills in accurately recognizing various emotions and effectively applying diverse emotion regulation strategies. To achieve this, the program includes video-based psychoeducation sessions. Alongside these sessions, the program incorporates daily short exercises, each lasting approximately five minutes. These exercises are crafted to help participants practically integrate the concepts and strategies learned from the psychoeducation sessions into their everyday lives. All components of the intervention are accessible through an online platform, ensuring ease of access and flexibility for participants.
Changes in Emotion Regulation Difficulties
The Difficulties in Emotion Regulation Scale (DERS; Gratz \& Roemer, 2004)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Emotion Regulation Strategy Use
The Heidelberg Form for Emotion Regulation Strategies (HFERST; Izadpanah et al., 2019)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Well-Being
The World Health Organization Well-Being Index (WHO-5; Topp et al., 2015)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Anxiety Symptoms
The General Anxiety Disorder Scale (GAD-7; Spitzer et al., 2006)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Depressive Symptoms
The Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Eating Psychopathology
The Eating Disorders Examination Questionnaire (EDE-Q; Berg et al., 2012)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Personality Pathology
The Personality Inventory for DSM-5 (PID-5; Krueger et al., 2012)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Eating-Disorder-Related Daily Difficulties
The Clinical Impairment Assessment Questionnaire (CIA; Bohn et al., 2008)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Self-Esteem
The Rosenberg Self-Esteem Scale (RSES; Roth et al., 2008)
Time frame: 0 weeks, 4 weeks, 8 weeks
Changes in Weekly Emotion Regulation Strategy Use
Weekly assessment of emotion regulation strategies (adapted from Pruessner et al., 2023).
Time frame: 0 weeks, 1 weeks, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks
Changes in Weekly Positive and Negative Affect
Positive and Negative Affect Schedule - Expanded Form (16 items; PANAS-X; Watson \& Clark, 1994)
Time frame: 0 weeks, 1 weeks, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks
Changes in Weekly Eating Psychopathology
The Eating Disorders Examination Questionnaire (EDE-QS; Gideon et al., 2016)
Time frame: 0 weeks, 1 weeks, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks
Implicit Emotion Regulation Capacity
Responses to negative images (corrugator electromyogram, frontal alpha asymmetry, affect ratings) and heart rate variability during a laboratory resting period (Thayer \& Lane, 2000)
Time frame: 4 weeks
Negative Emotion Downregulation Ability
Changes in responses to negative images (corrugator electromyogram, frontal alpha asymmetry, affect ratings) following a downregulation instruction in a laboratory emotion regulation task (adapted from Ertl et al., 2013)
Time frame: 4 weeks
Positive Emotion Upregulation Ability
Changes in responses to positive images (corrugator electromyogram, frontal alpha asymmetry, affect ratings) following an upregulation instruction in a laboratory emotion regulation task (adapted from Cheng et al., 2023)
Time frame: 4 weeks
Plan to share: Yes — De-identified dataset
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: Data will be made available after the publication of the study results.
Access criteria: Open access, available upon request to ensure appropriate use.
Data sharing details ↗ · osf.io
Started May 2023 (actual). Primary completion is estimated for Jun 2025, 25 months after the start.
Of 391 non-industry interventional studies with no phase under Emotional Regulation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's planned 25 months is above that.
Counting every sponsor, half of 397 studies reached it within 17 months; a quarter within 6 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.